Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine

British Medical Journal

Volumn 313, Issue 7055, 1996, Pages 461-464

  Saillour, F ^a   Dabis, F ^a   Dupon, M ^b   Lacoste, D ^b   Trimoulet, P ^b   Rispal, P ^b   Monlun, E ^b   Ragnaud, J M ^b   Morlat, P ^b   Pellegrin, J L ^b   Fleury, H ^b   Couzigou, P ^b  

^a INSERM   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCE; HEPATITIS B; HEPATITIS C; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SEX DIFFERENCE; VIRUS TRANSMISSION;

EID: 9444241551     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7055.461     Document Type: Article

References (21)

1. Kwo G, Choo HL, Alter HJ. An assay for circulating antibodies to a major etiologic virus of human non A, non B hepatitis. Science 1989;244:362-4.
2. Baath L, Widell A, Nordenfelt E. A comparison between one first generation and three second generation anti-HCV ELISAS: an investigation in high and low risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction. J Virol Methods 1992;40:287-96.
3. Dabis F, Chene G, Salamon R, GECSA. Hospital-based surveillance of HIV infection: Bordeaux, France, 1983-1990. AIDS 1991;5:774-5.
4. Brice L, Garros B. Le dépistage des séropositivités au VIH en Aquitaine de 1989 à 1993. Solidarité Santé 1994;3:47-59.
5. Quan CM, Krajden M, Grigorien GA, Salit IE. Hepatitis C virus infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1993;17:117-9.
6. Sherman KE, Freeman S, Harrison S, Andron L. Prevalence of antibody to hepatitis C virus in patients infected with human immunodeficiency virus. J Infect Dis 1991;163:414-5.
7. Wright TL, Hollander H, Xiang PU. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 1994;20:1152-5.
8. Nubling CM, Von Wangenheim G, Staszeuski S, Lower J. Hepatitis C virus antibody prevalence among human immunodeficiency virus type 1 infected individuals: analysis with different test systems. J Med Virol 1994;44:49-53.
9. Ladner J,Brossard G, Dabis F, Morlat P, Rogues AM, GECSA. Séroprévalence de l'hepatite virale C chez les sujets infectes par le virus de l'Immunodéficience humaine. Presse Med 1992;21:219.
10. Esteban JI, Viladomiu L, Gonzalez A. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989:ii:294-7.
11. Kleinham S, Alter H, Bush M, Holand P, Tegtmeier G, Nelles M, et al. Increased detection of hepatitis C virus (HCV) infected blood donors by a multiple antigen HCV enzyme immunoassay. Transfusion 1992;32:805-13.
12. Aoki SK, Holland PV, Fernando LP. Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C. Blood 1993;82:1000-5.
13. Pillonel J, Courouce AM, Laporte A, Brunet JB. Le dépistage du VIH, de la syphilis et des hepatites B et C dans les etablissements de transfusion sanguine. Bulletin Epidemiologique Hebdomadaire 1992;39:185-8.
14. Réseau National de Santé Publique. Groupe de l'Action concertée Hépatite C: résultats et propositions. Saint Maurice, France: RNSP, 1995.
15. Lebovics E, Dworkin BM, Heier SK, Rosenthal WS The hepatobiliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol 1988;83:1-7.
16. Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors and viral interactions. Epidemiol Rev 1994;16:418-36.
17. Dietzman DE, Hamisch JP, Ray CG, Alexander ER, Holmes KK. Hepatitis B surface antigen (HBsAg) and antibody to HBsAg: prevalence in homosexual and heterosexual men. JAMA 1977;238:2625-6.
18. Sheen IS, Liaw YF, Chu CM, Pao CC. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992;165:831-4.
19. Fong TL, di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991;14:64-7.
20. Flomenberg P, Balliet K, Bernstein B, Gutierrez E, Carrigan D, High specificity of hepatitis C second-generation enzyme immunoassay in HIV-infected patients. AIDS 1995;9:97-8.
21. Iwarson S, Norkrans G, Wejstål R, Hepatitis C: natural history of a unique infection. Clin Infect Dis 1995;20:1361-70.